Is the C-reactive protein/albumin ratio a prognostic and predictive factor in sudden hearing loss?
Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions....
Saved in:
| Published in | Brazilian journal of otorhinolaryngology Vol. 86; no. 2; pp. 180 - 184 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Brazil
Elsevier Editora Ltda
01.03.2020
Elsevier Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1808-8694 1808-8686 1808-8686 |
| DOI | 10.1016/j.bjorl.2018.10.007 |
Cover
| Abstract | Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions.
The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio.
A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests.
The patients included 16 females and 24 males with a mean age of 44.1±14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2±13.8 years. The mean C-reactive protein/albumin ratio was 0.95±0.47 in the patient group and 0.74±0.13 in the control group. The difference was statistically significant (p=0.009). The mean C-reactive protein/albumin ratio was 0.79±0.12 in the response to treatment group and 1.27±0.72 in the non-response group, with no significant difference determined between the groups (p=0.418). The mean neutrophil/lymphocyte ratio was 3.52±3.00 in the response to treatment group and 4.90±4.60 in the non-response group, with no statistically significant difference determined between the groups (p=0.261).
C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant.
A perda auditiva neurossensorial súbita ou surdez súbita é uma emergência otológica significativa. Estudos anteriores revelaram uma coexistência dessa condição com inflamação crônica. A importância preditiva dos valores da relação proteína C-reativa/albumina como fator prognóstico tem sido demonstrada em várias condições inflamatórias e tumorais.
O objetivo deste estudo foi determinar se a relação proteína C-reativa/albumina na perda auditiva neurossensorial súbita pode ser usada para fins prognósticos e se existe uma associação entre as relações neutrófilo/linfócito e proteína C-reativa/albumina.
Foram avaliados retrospectivamente 40 pacientes com diagnóstico de perda auditiva neurossensorial súbita idiopática e um grupo controle de 45 indivíduos saudáveis. As médias de tons puros de todos os pacientes foram determinadas na primeira consulta e repetidas 3 meses após o tratamento. Os pacientes foram separados em 2 grupos de acordo com a resposta ao tratamento. As relações neutrófilo/linfócito e proteína C-reativa/albumina foram calculadas a partir de testes laboratoriais.
Os pacientes incluíam 16 mulheres e 24 homens, com média de 44,1±14,2 anos, e o grupo controle por 23 mulheres e 22 homens, com média de 42,2±13,8 anos. A média da relação proteína C-reativa/albumina foi de 0,95±0,47 no grupo de pacientes e de 0,74±0,13 no grupo controle e a diferença foi estatisticamente significante (p=0,009). A média da relação proteína C-reativa/albumina foi de 0,79±0,12 do grupo com resposta ao tratamento e de 1,27±0,72 no grupo sem resposta, sem diferença significante entre os grupos (p=0,418). A média da relação neutrófilo/linfócito foi de 3,52±3,00 no grupo com resposta ao tratamento e de 4,90±4,60 no grupo sem resposta, sem diferença estatisticamente significativa entre os grupos (p=0,261).
A relação proteína C-reativa/albumina foi significantemente maior nos pacientes com perda auditiva neurossensorial súbita do que no grupo controle. No entanto, embora a relação proteína C-reativa/albumina tenha sido menor nos pacientes com perda auditiva neurossensorial súbita que responderam ao tratamento em comparação a aqueles que não apresentaram resposta, a diferença entre os dois grupos não foi estatisticamente significante. |
|---|---|
| AbstractList | Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions.
The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio.
A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests.
The patients included 16 females and 24 males with a mean age of 44.1±14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2±13.8 years. The mean C-reactive protein/albumin ratio was 0.95±0.47 in the patient group and 0.74±0.13 in the control group. The difference was statistically significant (p=0.009). The mean C-reactive protein/albumin ratio was 0.79±0.12 in the response to treatment group and 1.27±0.72 in the non-response group, with no significant difference determined between the groups (p=0.418). The mean neutrophil/lymphocyte ratio was 3.52±3.00 in the response to treatment group and 4.90±4.60 in the non-response group, with no statistically significant difference determined between the groups (p=0.261).
C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant. Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions.INTRODUCTIONSudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions.The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio.OBJECTIVESThe aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio.A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests.METHODSA retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests.The patients included 16 females and 24 males with a mean age of 44.1±14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2±13.8 years. The mean C-reactive protein/albumin ratio was 0.95±0.47 in the patient group and 0.74±0.13 in the control group. The difference was statistically significant (p=0.009). The mean C-reactive protein/albumin ratio was 0.79±0.12 in the response to treatment group and 1.27±0.72 in the non-response group, with no significant difference determined between the groups (p=0.418). The mean neutrophil/lymphocyte ratio was 3.52±3.00 in the response to treatment group and 4.90±4.60 in the non-response group, with no statistically significant difference determined between the groups (p=0.261).RESULTSThe patients included 16 females and 24 males with a mean age of 44.1±14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2±13.8 years. The mean C-reactive protein/albumin ratio was 0.95±0.47 in the patient group and 0.74±0.13 in the control group. The difference was statistically significant (p=0.009). The mean C-reactive protein/albumin ratio was 0.79±0.12 in the response to treatment group and 1.27±0.72 in the non-response group, with no significant difference determined between the groups (p=0.418). The mean neutrophil/lymphocyte ratio was 3.52±3.00 in the response to treatment group and 4.90±4.60 in the non-response group, with no statistically significant difference determined between the groups (p=0.261).C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant.CONCLUSIONC-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant. Introduction: Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions. Objectives: The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio. Methods: A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests. Results: The patients included 16 females and 24 males with a mean age of 44.1 ± 14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2 ± 13.8 years. The mean C-reactive protein/albumin ratio was 0.95 ± 0.47 in the patient group and 0.74 ± 0.13 in the control group. The difference was statistically significant (p = 0.009). The mean C-reactive protein/albumin ratio was 0.79 ± 0.12 in the response to treatment group and 1.27 ± 0.72 in the non-response group, with no significant difference determined between the groups (p = 0.418). The mean neutrophil/lymphocyte ratio was 3.52 ± 3.00 in the response to treatment group and 4.90 ± 4.60 in the non-response group, with no statistically significant difference determined between the groups (p = 0.261). Conclusion: C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant. Resumo: Introdução: A perda auditiva neurossensorial súbita ou surdez súbita é uma emergência otológica significativa. Estudos anteriores revelaram uma coexistência dessa condição com inflamação crônica. A importância preditiva dos valores da relação proteína C-reativa/albumina como fator prognóstico tem sido demonstrada em várias condições inflamatórias e tumorais. Objetivos: O objetivo deste estudo foi determinar se a relação proteína C-reativa/albumina na perda auditiva neurossensorial súbita pode ser usada para fins prognósticos e se existe uma associação entre as relações neutrófilo/linfócito e proteína C-reativa/albumina. Método: Foram avaliados retrospectivamente 40 pacientes com diagnóstico de perda auditiva neurossensorial súbita idiopática e um grupo controle de 45 indivíduos saudáveis. As médias de tons puros de todos os pacientes foram determinadas na primeira consulta e repetidas 3 meses após o tratamento. Os pacientes foram separados em 2 grupos de acordo com a resposta ao tratamento. As relações neutrófilo/linfócito e proteína C-reativa/albumina foram calculadas a partir de testes laboratoriais. Resultados: Os pacientes incluíam 16 mulheres e 24 homens, com média de 44,1 ± 14,2 anos, e o grupo controle por 23 mulheres e 22 homens, com média de 42,2 ± 13,8 anos. A média da relação proteína C-reativa/albumina foi de 0,95 ± 0,47 no grupo de pacientes e de 0,74 ± 0,13 no grupo controle e a diferença foi estatisticamente significante (p = 0,009). A média da relação proteína C-reativa/albumina foi de 0,79 ± 0,12 do grupo com resposta ao tratamento e de 1,27 ± 0,72 no grupo sem resposta, sem diferença significante entre os grupos (p = 0,418). A média da relação neutrófilo/linfócito foi de 3,52 ± 3,00 no grupo com resposta ao tratamento e de 4,90 ± 4,60 no grupo sem resposta, sem diferença estatisticamente significativa entre os grupos (p = 0,261). Conclusão: A relação proteína C-reativa/albumina foi significantemente maior nos pacientes com perda auditiva neurossensorial súbita do que no grupo controle. No entanto, embora a relação proteína C-reativa/albumina tenha sido menor nos pacientes com perda auditiva neurossensorial súbita que responderam ao tratamento em comparação a aqueles que não apresentaram resposta, a diferença entre os dois grupos não foi estatisticamente significante. Keywords: Sudden hearing loss, C-reactive protein, Albumin, Chronic inflammation, Palavras-chave: Perda auditiva súbita, Proteína C-reativa, Albumina, Inflamação crônica Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions. The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio. A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests. The patients included 16 females and 24 males with a mean age of 44.1±14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2±13.8 years. The mean C-reactive protein/albumin ratio was 0.95±0.47 in the patient group and 0.74±0.13 in the control group. The difference was statistically significant (p=0.009). The mean C-reactive protein/albumin ratio was 0.79±0.12 in the response to treatment group and 1.27±0.72 in the non-response group, with no significant difference determined between the groups (p=0.418). The mean neutrophil/lymphocyte ratio was 3.52±3.00 in the response to treatment group and 4.90±4.60 in the non-response group, with no statistically significant difference determined between the groups (p=0.261). C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant. A perda auditiva neurossensorial súbita ou surdez súbita é uma emergência otológica significativa. Estudos anteriores revelaram uma coexistência dessa condição com inflamação crônica. A importância preditiva dos valores da relação proteína C-reativa/albumina como fator prognóstico tem sido demonstrada em várias condições inflamatórias e tumorais. O objetivo deste estudo foi determinar se a relação proteína C-reativa/albumina na perda auditiva neurossensorial súbita pode ser usada para fins prognósticos e se existe uma associação entre as relações neutrófilo/linfócito e proteína C-reativa/albumina. Foram avaliados retrospectivamente 40 pacientes com diagnóstico de perda auditiva neurossensorial súbita idiopática e um grupo controle de 45 indivíduos saudáveis. As médias de tons puros de todos os pacientes foram determinadas na primeira consulta e repetidas 3 meses após o tratamento. Os pacientes foram separados em 2 grupos de acordo com a resposta ao tratamento. As relações neutrófilo/linfócito e proteína C-reativa/albumina foram calculadas a partir de testes laboratoriais. Os pacientes incluíam 16 mulheres e 24 homens, com média de 44,1±14,2 anos, e o grupo controle por 23 mulheres e 22 homens, com média de 42,2±13,8 anos. A média da relação proteína C-reativa/albumina foi de 0,95±0,47 no grupo de pacientes e de 0,74±0,13 no grupo controle e a diferença foi estatisticamente significante (p=0,009). A média da relação proteína C-reativa/albumina foi de 0,79±0,12 do grupo com resposta ao tratamento e de 1,27±0,72 no grupo sem resposta, sem diferença significante entre os grupos (p=0,418). A média da relação neutrófilo/linfócito foi de 3,52±3,00 no grupo com resposta ao tratamento e de 4,90±4,60 no grupo sem resposta, sem diferença estatisticamente significativa entre os grupos (p=0,261). A relação proteína C-reativa/albumina foi significantemente maior nos pacientes com perda auditiva neurossensorial súbita do que no grupo controle. No entanto, embora a relação proteína C-reativa/albumina tenha sido menor nos pacientes com perda auditiva neurossensorial súbita que responderam ao tratamento em comparação a aqueles que não apresentaram resposta, a diferença entre os dois grupos não foi estatisticamente significante. Abstract Introduction: Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The predictive importance of C-reactive protein/albumin values as a prognostic factor has been shown in various inflammatory and tumoral conditions. Objectives: The aim of this study was to determine whether the C-reactive protein/albumin ratio in sudden hearing loss can be used for prognostic purposes and whether there is a relationship between the neutrophil/lymphocyte ratio and the C-reactive protein/albumin ratio. Methods: A retrospective examination was made of 40 patients diagnosed with idiopathic sudden hearing loss and a control group of 45 healthy subjects. The pure tone averages of all the patients were determined on first presentation and repeated at 3 months after the treatment. The patients were separated into 2 groups according to the response to treatment. The neutrophil/lynphocyte ratio and the C-reactive protein/albumin ratios were calculated from the laboratory tests. Results: The patients included 16 females and 24 males with a mean age of 44.1 ± 14.2 years and the control group was composed of 23 females and 22 males with a mean age of 42.2 ± 13.8 years. The mean C-reactive protein/albumin ratio was 0.95 ± 0.47 in the patient group and 0.74 ± 0.13 in the control group. The difference was statistically significant (p = 0.009). The mean C-reactive protein/albumin ratio was 0.79 ± 0.12 in the response to treatment group and 1.27 ± 0.72 in the non-response group, with no significant difference determined between the groups (p = 0.418). The mean neutrophil/lymphocyte ratio was 3.52 ± 3.00 in the response to treatment group and 4.90 ± 4.60 in the non-response group, with no statistically significant difference determined between the groups (p = 0.261). Conclusion: C-reactive/albumin ratio was significantly higher in patients with sudden hearing loss than in the control group. Although C-reactive protein/albumin ratio was found to be lower in sudden hearing loss patients who responded to treatment compared to those who did not, the difference between two groups was not statistically significant. |
| Author | Alataş, Necat Akın Öçal, Fatma Ceyda Güllüev, Mustafa Öçal, Ramazan |
| AuthorAffiliation | Health Sciences University |
| AuthorAffiliation_xml | – name: Health Sciences University |
| Author_xml | – sequence: 1 givenname: Ramazan orcidid: 0000-0002-9087-4806 surname: Öçal fullname: Öçal, Ramazan email: drramazanocal@gmail.com organization: Health Sciences University, Ankara Training and Research Hospital, Department of Otolaryngology Head and Neck Surgery, Ankara, Turkey – sequence: 2 givenname: Fatma Ceyda surname: Akın Öçal fullname: Akın Öçal, Fatma Ceyda organization: Health Sciences University, Gülhane Training and Research Hospital, Department of Otolaryngology Head and Neck Surgery, Ankara, Turkey – sequence: 3 givenname: Mustafa surname: Güllüev fullname: Güllüev, Mustafa organization: Health Sciences University, Konya Training and Research Hospital, Department of Otolaryngology Head and Neck Surgery, Konya, Turkey – sequence: 4 givenname: Necat surname: Alataş fullname: Alataş, Necat organization: Health Sciences University, Konya Training and Research Hospital, Department of Otolaryngology Head and Neck Surgery, Konya, Turkey |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30522831$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkk1v1DAQhiNURD_gFyChHLns1p-JIwQIrSisVIkDcLYce7Lr4LUXO1mp_x6naVe0l80hccbv83o8M5fFmQ8eiuItRkuMcHXdL9s-RLckCIscWSJUvygusEBiISpRnR3XDTsvLlPqEapqVPNXxTlFnBBB8UXRrlM5bKFcLSIoPdgDlPsYBrD-Wrl23FlfRjXYUKopvvEhDVaXypv8C8bORJfJEMusTaMx4MstqGj9pnQhpc-vi5edcgnePHyvit83X3-tvi9uf3xbr77cLnSFq2FBcctaKkhHGDBklDBEVJopxY3qGFAgVAtTMc4E5Q1g0J0hTDSCQ2uEQvSqWM--Jqhe7qPdqXgng7LyPhDiRqqYs3cga9YJrptGmRqzrm2a1jDCa8pwjVSFTfZazl5JW3BB9mGMPicvf041lVNNCSIoP_mVQxn4NAP7sd2B0eCHqNyTLJ7ueLuVm3CQ2YgwKrLB-weDGP6OkAa5s0mDc8pDGJMkmHPR5NvzLH33_1nHQx67mgV0FuiYGxChO0owktPsyF7ez46cZmcK5tnJVPOM0naYej8lbN0J9uPMQm7wwUKUU-G8ziMSQQ-5A_YE_-EZr531Viv3B-5O0v8AHIbzOA |
| CitedBy_id | crossref_primary_10_1097_MAO_0000000000004035 crossref_primary_10_1016_j_clinbiochem_2023_110684 crossref_primary_10_1007_s00403_024_03418_x crossref_primary_10_1177_0145561320960355 crossref_primary_10_38175_phnx_1239411 crossref_primary_10_1016_j_bjorl_2020_06_010 crossref_primary_10_1007_s00405_022_07806_9 crossref_primary_10_1016_j_amjoto_2022_103455 crossref_primary_10_54005_geneltip_996818 crossref_primary_10_3390_medicina58070963 crossref_primary_10_1007_s00405_024_08684_z crossref_primary_10_1177_01455613241306030 crossref_primary_10_3390_ijms21197248 crossref_primary_10_3390_medicina59101718 |
| Cites_doi | 10.1097/MAO.0b013e3182635417 10.1016/j.trsl.2012.01.001 10.1016/j.jcrc.2009.12.004 10.1186/cc4892 10.1038/srep10481 10.1086/430382 10.1016/S0030-6665(20)32783-3 10.1016/j.tranon.2015.06.006 10.1007/BF01692917 10.1177/000348947708600406 10.1001/archotol.1980.00790360050013 10.1097/01.mao.0000224092.79635.ee 10.1016/S0140-6736(09)62071-7 10.1097/MAO.0b013e31829b57df 10.1038/jcbfm.2008.141 10.1245/s10434-014-4048-0 10.12659/MSM.897460 10.1007/s00134-007-0928-0 10.3109/01677063.2011.652266 10.1111/j.0894-0959.2004.17603.x 10.1002/jnr.20764 10.1016/j.anorl.2016.06.005 10.1186/s12885-015-1379-6 10.7150/jca.15401 |
| ContentType | Journal Article |
| Copyright | 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial Copyright © 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial This work is licensed under a Creative Commons Attribution 4.0 International License. |
| Copyright_xml | – notice: 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial – notice: Copyright © 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. – notice: 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial – notice: This work is licensed under a Creative Commons Attribution 4.0 International License. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM GPN DOA |
| DOI | 10.1016/j.bjorl.2018.10.007 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) SciELO DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| DocumentTitleAlternate | A relação proteína C-reativa/albumina é um fator prognóstico e preditivo na surdez súbita? |
| EISSN | 1808-8686 |
| EndPage | 184 |
| ExternalDocumentID | oai_doaj_org_article_74f85c99ad714fb99bd425734170a61d S1808_86942020000200180 PMC9422438 30522831 10_1016_j_bjorl_2018_10_007 S1808869418302611 |
| Genre | Journal Article |
| GroupedDBID | --- .1- .FO 0R~ 1P~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO ABMAC ABXHO ACGFS ACVFH ADBBV ADCNI ADEZE ADVLN AENEX AEUPX AEVXI AEXQZ AFJKZ AFPUW AFRHN AFTJW AGHFR AIGII AITUG AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ APOWU APXCP AZFZN BAWUL BCNDV C1A DIK EBS EJD F5P FDB GROUPED_DOAJ GX1 HZ~ IPNFZ IXB M41 O9- OG- OR0 P6G RIG RNS ROL RPM RSC SCD SSZ TR2 Z5R 0SF 6I. AACTN AAFTH AFCTW M~E NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM GPN |
| ID | FETCH-LOGICAL-c616t-31b4b382f24e40da8d286c4aa5daf4e3e23c8d64548359e1ecfd248985ebd8a03 |
| IEDL.DBID | IXB |
| ISSN | 1808-8694 1808-8686 |
| IngestDate | Wed Aug 27 01:29:39 EDT 2025 Tue Sep 16 20:22:43 EDT 2025 Thu Aug 21 18:36:10 EDT 2025 Fri Sep 05 07:52:54 EDT 2025 Thu Apr 03 06:59:01 EDT 2025 Tue Jul 01 00:57:16 EDT 2025 Thu Apr 24 22:57:49 EDT 2025 Wed May 17 01:39:46 EDT 2023 Tue Aug 26 16:34:09 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Albumina C-reactive protein Chronic inflammation Sudden hearing loss Perda auditiva súbita Albumin Proteína C-reativa Inflamação crônica |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2018 Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial. Published by Elsevier Editora Ltda. All rights reserved. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). This work is licensed under a Creative Commons Attribution 4.0 International License. http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c616t-31b4b382f24e40da8d286c4aa5daf4e3e23c8d64548359e1ecfd248985ebd8a03 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-9087-4806 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S1808869418302611 |
| PMID | 30522831 |
| PQID | 2155894545 |
| PQPubID | 23479 |
| PageCount | 5 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_74f85c99ad714fb99bd425734170a61d scielo_journals_S1808_86942020000200180 pubmedcentral_primary_oai_pubmedcentral_nih_gov_9422438 proquest_miscellaneous_2155894545 pubmed_primary_30522831 crossref_primary_10_1016_j_bjorl_2018_10_007 crossref_citationtrail_10_1016_j_bjorl_2018_10_007 elsevier_sciencedirect_doi_10_1016_j_bjorl_2018_10_007 elsevier_clinicalkey_doi_10_1016_j_bjorl_2018_10_007 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-03-01 |
| PublicationDateYYYYMMDD | 2020-03-01 |
| PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-01 day: 01 |
| PublicationDecade | 2020 |
| PublicationPlace | Brazil |
| PublicationPlace_xml | – name: Brazil |
| PublicationTitle | Brazilian journal of otorhinolaryngology |
| PublicationTitleAlternate | Braz J Otorhinolaryngol |
| PublicationYear | 2020 |
| Publisher | Elsevier Editora Ltda Elsevier Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial |
| Publisher_xml | – name: Elsevier Editora Ltda – name: Elsevier – name: Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial |
| References | Mattox, Simmons (bib0125) 1977; 86 Siegel (bib0200) 1975; 8 Don, Kaysen (bib0175) 2004; 17 Schreiber, Agrup, Haskard, Luxon (bib0130) 2010; 375 Fujioka, Kanzaki, Okano, Masuda, Ogawa, Okano (bib0205) 2006; 83 Iskandar, Ciorba (bib0170) 2012; 159 Qin, Tu, Liu, Luo, Wu, Tao (bib0195) 2016; 22 Wilson, Byl, Laird (bib0145) 1980; 106 Suzuki, Tanaka, Suzuki (bib0210) 2009; 29 Kakehata, Sasaki, Oji, Futai, Ota, Makinea (bib0215) 2006; 27 Povoa, Coelho, Almeida, Fernandes, Mealha, Moreira (bib0165) 2005; 40 Zhang, Zhou, Liu, Chen, Li, Tang (bib0240) 2016; 7 Masuda, Kanzaki, Minami, Kikuchi, Kanzaki, Sato (bib0140) 2012; 33 Artero, Zaragoza, Camarena, Sancho, Gonzalez, Nogueira (bib0225) 2010; 25 Hiramatsu, Teranishi, Uchida, Nishio, Suzuki, Kato (bib0135) 2012; 26 Ulu, Ulu, Bucak, Ahsen, Yucedag, Aycicek (bib0150) 2013; 34 Wei, Wang, Zhang, Qiu, Ren, Jin (bib0235) 2015; 15 Kinoshita, Onoda, Imai, Iwaku, Oishi, Tanaka (bib0190) 2015; 22 Zhou, Zhan, Hong, Hu, Fang, Qin (bib0185) 2015; 5 Liu, Sun, Liu, Kong, Chen, Zhan (bib0180) 2015; 8 Koçak, Elbistanlı, Acıpayam, Alakras, Kıral, Kayhan (bib0155) 2017; 134 Povoa, Coelho, Almeida, Fernandes, Mealha, Moreira (bib0160) 2006; 10 Ho, Lee, Dobb, Webb (bib0220) 2008; 34 Dominguez de Villota, Mosquera, Rubio, Galdos, Diez Balda, de la Serna (bib0230) 1980; 7 Iskandar (10.1016/j.bjorl.2018.10.007_bib0170) 2012; 159 Zhou (10.1016/j.bjorl.2018.10.007_bib0185) 2015; 5 Koçak (10.1016/j.bjorl.2018.10.007_bib0155) 2017; 134 Qin (10.1016/j.bjorl.2018.10.007_bib0195) 2016; 22 Ho (10.1016/j.bjorl.2018.10.007_bib0220) 2008; 34 Wei (10.1016/j.bjorl.2018.10.007_bib0235) 2015; 15 Fujioka (10.1016/j.bjorl.2018.10.007_bib0205) 2006; 83 Siegel (10.1016/j.bjorl.2018.10.007_bib0200) 1975; 8 Dominguez de Villota (10.1016/j.bjorl.2018.10.007_bib0230) 1980; 7 Schreiber (10.1016/j.bjorl.2018.10.007_bib0130) 2010; 375 Artero (10.1016/j.bjorl.2018.10.007_bib0225) 2010; 25 Masuda (10.1016/j.bjorl.2018.10.007_bib0140) 2012; 33 Suzuki (10.1016/j.bjorl.2018.10.007_bib0210) 2009; 29 Ulu (10.1016/j.bjorl.2018.10.007_bib0150) 2013; 34 Povoa (10.1016/j.bjorl.2018.10.007_bib0165) 2005; 40 Wilson (10.1016/j.bjorl.2018.10.007_bib0145) 1980; 106 Zhang (10.1016/j.bjorl.2018.10.007_bib0240) 2016; 7 Hiramatsu (10.1016/j.bjorl.2018.10.007_bib0135) 2012; 26 Liu (10.1016/j.bjorl.2018.10.007_bib0180) 2015; 8 Povoa (10.1016/j.bjorl.2018.10.007_bib0160) 2006; 10 Don (10.1016/j.bjorl.2018.10.007_bib0175) 2004; 17 Mattox (10.1016/j.bjorl.2018.10.007_bib0125) 1977; 86 Kakehata (10.1016/j.bjorl.2018.10.007_bib0215) 2006; 27 Kinoshita (10.1016/j.bjorl.2018.10.007_bib0190) 2015; 22 Mattox, DE; Simmons, FB 1977; 86 Koçak, HE; Elbistanlı, MS; Acıpayam, H; Alakras, WME; Kıral, MN; Kayhan, FT 2017; 134 Fujioka, M; Kanzaki, S; Okano, HJ; Masuda, M; Ogawa, K; Okano, H 2006; 83 Schreiber, BE; Agrup, C; Haskard, DO; Luxon, LM 2010; 375 Dominguez de Villota, E; Mosquera, JM; Rubio, JJ; Galdos, P; Diez Balda, V; de la Serna, JL 1980; 7 Iskandar, HN; Ciorba, MA 2012; 159 Povoa, P; Coelho, L; Almeida, E; Fernandes, A; Mealha, R; Moreira, P 2006; 10 Kinoshita, A; Onoda, H; Imai, N; Iwaku, A; Oishi, M; Tanaka, K 2015; 22 Siegel, LG 1975; 8 Kakehata, S; Sasaki, A; Oji, K; Futai, K; Ota, S; Makinea, K 2006; 27 Zhang, Y; Zhou, GQ; Liu, X; Chen, L; Li, WF; Tang, LL 2016; 7 Wilson, WR; Byl, FM; Laird, N 1980; 106 Masuda, M; Kanzaki, S; Minami, S; Kikuchi, J; Kanzaki, J; Sato, H 2012; 33 Povoa, P; Coelho, L; Almeida, E; Fernandes, A; Mealha, R; Moreira, P 2005; 40 Artero, A; Zaragoza, R; Camarena, JJ; Sancho, S; Gonzalez, R; Nogueira, JM 2010; 25 Hiramatsu, M; Teranishi, M; Uchida, Y; Nishio, N; Suzuki, H; Kato, K 2012; 26 Suzuki, S; Tanaka, K; Suzuki, N 2009; 29 Wei, XL; Wang, FH; Zhang, DS; Qiu, MZ; Ren, C; Jin, Y 2015; 15 Don, BR; Kaysen, G 2004; 17 Zhou, T; Zhan, J; Hong, S; Hu, Z; Fang, W; Qin, T 2015; 5 Qin, GM; Tu, JF; Liu, LG; Luo, L; Wu, J; Tao, L 2016; 22 Ho, KM; Lee, KY; Dobb, GJ; Webb, SA 2008; 34 Liu, X; Sun, X; Liu, J; Kong, P; Chen, S; Zhan, Y 2015; 8 Ulu, S; Ulu, MS; Bucak, A; Ahsen, A; Yucedag, F; Aycicek, A 2013; 34 |
| References_xml | – volume: 5 start-page: 10481 year: 2015 ident: bib0185 article-title: Ratio of Creactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer publication-title: Sci Rep – volume: 15 start-page: 350 year: 2015 ident: bib0235 article-title: A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio publication-title: BMC Cancer – volume: 25 start-page: 276 year: 2010 end-page: 281 ident: bib0225 article-title: Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock publication-title: J Crit Care – volume: 375 start-page: 1203 year: 2010 end-page: 1211 ident: bib0130 article-title: Sudden sensorineural hearing loss publication-title: Lancet – volume: 34 start-page: 481 year: 2008 end-page: 487 ident: bib0220 article-title: C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study publication-title: Intensive Care Med – volume: 7 start-page: 1406 year: 2016 end-page: 1412 ident: bib0240 article-title: Exploration and validation of C-reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma publication-title: J Cancer – volume: 26 start-page: 387 year: 2012 end-page: 396 ident: bib0135 article-title: Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss publication-title: J Neurogenet – volume: 27 start-page: 604 year: 2006 end-page: 608 ident: bib0215 article-title: Comparison of intratympanic and intravenous dexamethasone treatment of sudden senorineural hearing loss with diabetes publication-title: Otol Neurotol – volume: 8 start-page: 339 year: 2015 end-page: 345 ident: bib0180 article-title: Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer publication-title: Transl Oncol – volume: 159 start-page: 313 year: 2012 end-page: 325 ident: bib0170 article-title: Biomarkers in inflammatory bowel disease: current practices and recent advances publication-title: Transl Res – volume: 17 start-page: 432 year: 2004 end-page: 437 ident: bib0175 article-title: Serum albumin: relationship to inflammation and nutrition publication-title: Semin Dial – volume: 22 start-page: 4393 year: 2016 end-page: 4400 ident: bib0195 article-title: Serum albumin and C-reactive protein/albumin ratio are useful biomarkers of Crohn's disease activity publication-title: Med Sci Monit – volume: 40 start-page: 1855 year: 2005 end-page: 1857 ident: bib0165 article-title: Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection publication-title: Clin Infect Dis – volume: 106 start-page: 772 year: 1980 end-page: 776 ident: bib0145 article-title: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study publication-title: Arch Otolaryngol – volume: 86 start-page: 463 year: 1977 end-page: 468 ident: bib0125 article-title: Natural history of sudden sensorineural hearing loss publication-title: Ann Otol Rhinol Laryngol – volume: 29 start-page: 464 year: 2009 end-page: 479 ident: bib0210 article-title: Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects publication-title: J Cereb Blood Flow Metab – volume: 7 start-page: 19 year: 1980 end-page: 22 ident: bib0230 article-title: Association of a low serum albumin with infection and increased mortality in critically ill patients publication-title: Intensive Care Med – volume: 34 start-page: 1400 year: 2013 end-page: 1404 ident: bib0150 article-title: Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol – volume: 10 start-page: R63 year: 2006 ident: bib0160 article-title: Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study publication-title: Crit Care – volume: 22 start-page: 803 year: 2015 end-page: 810 ident: bib0190 article-title: The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma publication-title: Ann Surg Oncol – volume: 8 start-page: 467 year: 1975 ident: bib0200 article-title: The treatment of idiopathic sudden sensorineural hearing loss publication-title: Otolaryngol Clin North Am – volume: 33 start-page: 1142 year: 2012 end-page: 1150 ident: bib0140 article-title: Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol – volume: 83 start-page: 575 year: 2006 end-page: 583 ident: bib0205 article-title: Proinflammatory cytokines expression in noise-induced damaged cochlea publication-title: J Neurosci Res – volume: 134 start-page: 383 year: 2017 end-page: 386 ident: bib0155 article-title: Are neutrophil/lymphocyte and platelet/lymphocyte ratios related with formation of sudden hearing loss and its prognosis? publication-title: Eur Ann Otorhinolaryngol Head Neck Dis – volume: 33 start-page: 1142 year: 2012 ident: 10.1016/j.bjorl.2018.10.007_bib0140 article-title: Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol doi: 10.1097/MAO.0b013e3182635417 – volume: 159 start-page: 313 year: 2012 ident: 10.1016/j.bjorl.2018.10.007_bib0170 article-title: Biomarkers in inflammatory bowel disease: current practices and recent advances publication-title: Transl Res doi: 10.1016/j.trsl.2012.01.001 – volume: 25 start-page: 276 year: 2010 ident: 10.1016/j.bjorl.2018.10.007_bib0225 article-title: Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock publication-title: J Crit Care doi: 10.1016/j.jcrc.2009.12.004 – volume: 10 start-page: R63 year: 2006 ident: 10.1016/j.bjorl.2018.10.007_bib0160 article-title: Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study publication-title: Crit Care doi: 10.1186/cc4892 – volume: 5 start-page: 10481 year: 2015 ident: 10.1016/j.bjorl.2018.10.007_bib0185 article-title: Ratio of Creactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer publication-title: Sci Rep doi: 10.1038/srep10481 – volume: 40 start-page: 1855 year: 2005 ident: 10.1016/j.bjorl.2018.10.007_bib0165 article-title: Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection publication-title: Clin Infect Dis doi: 10.1086/430382 – volume: 8 start-page: 467 year: 1975 ident: 10.1016/j.bjorl.2018.10.007_bib0200 article-title: The treatment of idiopathic sudden sensorineural hearing loss publication-title: Otolaryngol Clin North Am doi: 10.1016/S0030-6665(20)32783-3 – volume: 8 start-page: 339 year: 2015 ident: 10.1016/j.bjorl.2018.10.007_bib0180 article-title: Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer publication-title: Transl Oncol doi: 10.1016/j.tranon.2015.06.006 – volume: 7 start-page: 19 year: 1980 ident: 10.1016/j.bjorl.2018.10.007_bib0230 article-title: Association of a low serum albumin with infection and increased mortality in critically ill patients publication-title: Intensive Care Med doi: 10.1007/BF01692917 – volume: 86 start-page: 463 year: 1977 ident: 10.1016/j.bjorl.2018.10.007_bib0125 article-title: Natural history of sudden sensorineural hearing loss publication-title: Ann Otol Rhinol Laryngol doi: 10.1177/000348947708600406 – volume: 106 start-page: 772 year: 1980 ident: 10.1016/j.bjorl.2018.10.007_bib0145 article-title: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study publication-title: Arch Otolaryngol doi: 10.1001/archotol.1980.00790360050013 – volume: 27 start-page: 604 year: 2006 ident: 10.1016/j.bjorl.2018.10.007_bib0215 article-title: Comparison of intratympanic and intravenous dexamethasone treatment of sudden senorineural hearing loss with diabetes publication-title: Otol Neurotol doi: 10.1097/01.mao.0000224092.79635.ee – volume: 375 start-page: 1203 year: 2010 ident: 10.1016/j.bjorl.2018.10.007_bib0130 article-title: Sudden sensorineural hearing loss publication-title: Lancet doi: 10.1016/S0140-6736(09)62071-7 – volume: 34 start-page: 1400 year: 2013 ident: 10.1016/j.bjorl.2018.10.007_bib0150 article-title: Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol doi: 10.1097/MAO.0b013e31829b57df – volume: 29 start-page: 464 year: 2009 ident: 10.1016/j.bjorl.2018.10.007_bib0210 article-title: Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects publication-title: J Cereb Blood Flow Metab doi: 10.1038/jcbfm.2008.141 – volume: 22 start-page: 803 year: 2015 ident: 10.1016/j.bjorl.2018.10.007_bib0190 article-title: The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-4048-0 – volume: 22 start-page: 4393 year: 2016 ident: 10.1016/j.bjorl.2018.10.007_bib0195 article-title: Serum albumin and C-reactive protein/albumin ratio are useful biomarkers of Crohn's disease activity publication-title: Med Sci Monit doi: 10.12659/MSM.897460 – volume: 34 start-page: 481 year: 2008 ident: 10.1016/j.bjorl.2018.10.007_bib0220 article-title: C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study publication-title: Intensive Care Med doi: 10.1007/s00134-007-0928-0 – volume: 26 start-page: 387 year: 2012 ident: 10.1016/j.bjorl.2018.10.007_bib0135 article-title: Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss publication-title: J Neurogenet doi: 10.3109/01677063.2011.652266 – volume: 17 start-page: 432 year: 2004 ident: 10.1016/j.bjorl.2018.10.007_bib0175 article-title: Serum albumin: relationship to inflammation and nutrition publication-title: Semin Dial doi: 10.1111/j.0894-0959.2004.17603.x – volume: 83 start-page: 575 year: 2006 ident: 10.1016/j.bjorl.2018.10.007_bib0205 article-title: Proinflammatory cytokines expression in noise-induced damaged cochlea publication-title: J Neurosci Res doi: 10.1002/jnr.20764 – volume: 134 start-page: 383 year: 2017 ident: 10.1016/j.bjorl.2018.10.007_bib0155 article-title: Are neutrophil/lymphocyte and platelet/lymphocyte ratios related with formation of sudden hearing loss and its prognosis? publication-title: Eur Ann Otorhinolaryngol Head Neck Dis doi: 10.1016/j.anorl.2016.06.005 – volume: 15 start-page: 350 year: 2015 ident: 10.1016/j.bjorl.2018.10.007_bib0235 article-title: A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio publication-title: BMC Cancer doi: 10.1186/s12885-015-1379-6 – volume: 7 start-page: 1406 year: 2016 ident: 10.1016/j.bjorl.2018.10.007_bib0240 article-title: Exploration and validation of C-reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma publication-title: J Cancer doi: 10.7150/jca.15401 – volume: 8 start-page: 467 year: 1975 article-title: The treatment of idiopathic sudden sensorineural hearing loss publication-title: Otolaryngol Clin North Am – volume: 29 start-page: 464 year: 2009 end-page: 479 article-title: Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects publication-title: J Cereb Blood Flow Metab – volume: 159 start-page: 313 year: 2012 end-page: 325 article-title: Biomarkers in inflammatory bowel disease: current practices and recent advances publication-title: Transl Res – volume: 7 start-page: 1406 year: 2016 end-page: 1412 article-title: Exploration and validation of C-reactive protein/albumin ratio as a novel inflammation-based prognostic marker in nasopharyngeal carcinoma publication-title: J Cancer – volume: 134 start-page: 383 year: 2017 end-page: 386 article-title: Are neutrophil/lymphocyte and platelet/lymphocyte ratios related with formation of sudden hearing loss and its prognosis? publication-title: Eur Ann Otorhinolaryngol Head Neck Dis – volume: 26 start-page: 387 year: 2012 end-page: 396 article-title: Polymorphisms in genes involved in inflammatory pathways in patients with sudden sensorineural hearing loss publication-title: J Neurogenet – volume: 5 start-page: 10481 year: 2015 article-title: Ratio of Creactive protein/albumin is an inflammatory prognostic score for predicting overall survival of patients with small-cell lung cancer publication-title: Sci Rep – volume: 17 start-page: 432 year: 2004 end-page: 437 article-title: Serum albumin: relationship to inflammation and nutrition publication-title: Semin Dial – volume: 27 start-page: 604 year: 2006 end-page: 608 article-title: Comparison of intratympanic and intravenous dexamethasone treatment of sudden senorineural hearing loss with diabetes publication-title: Otol Neurotol – volume: 33 start-page: 1142 year: 2012 end-page: 1150 article-title: Correlations of inflammatory biomarkers with the onset and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol – volume: 83 start-page: 575 year: 2006 end-page: 583 article-title: Proinflammatory cytokines expression in noise-induced damaged cochlea publication-title: J Neurosci Res – volume: 25 start-page: 276 year: 2010 end-page: 281 article-title: Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock publication-title: J Crit Care – volume: 8 start-page: 339 year: 2015 end-page: 345 article-title: Preoperative C-reactive protein/albumin ratio predicts prognosis of patients after curative resection for gastric cancer publication-title: Transl Oncol – volume: 86 start-page: 463 year: 1977 end-page: 468 article-title: Natural history of sudden sensorineural hearing loss publication-title: Ann Otol Rhinol Laryngol – volume: 375 start-page: 1203 year: 2010 end-page: 1211 article-title: Sudden sensorineural hearing loss publication-title: Lancet – volume: 34 start-page: 1400 year: 2013 end-page: 1404 article-title: Neutrophil-to-lymphocyte ratio as a new, quick, and reliable indicator for predicting diagnosis and prognosis of idiopathic sudden sensorineural hearing loss publication-title: Otol Neurotol – volume: 22 start-page: 4393 year: 2016 end-page: 4400 article-title: Serum albumin and C-reactive protein/albumin ratio are useful biomarkers of Crohn's disease activity publication-title: Med Sci Monit – volume: 22 start-page: 803 year: 2015 end-page: 810 article-title: The C-reactive protein/albumin ratio, a novel inflammation-based prognostic score, predicts outcomes in patients with hepatocellular carcinoma publication-title: Ann Surg Oncol – volume: 7 start-page: 19 year: 1980 end-page: 22 article-title: Association of a low serum albumin with infection and increased mortality in critically ill patients publication-title: Intensive Care Med – volume: 15 start-page: 350 year: 2015 article-title: A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio publication-title: BMC Cancer – volume: 40 start-page: 1855 year: 2005 end-page: 1857 article-title: Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection publication-title: Clin Infect Dis – volume: 106 start-page: 772 year: 1980 end-page: 776 article-title: The efficacy of steroids in the treatment of idiopathic sudden hearing loss. A double-blind clinical study publication-title: Arch Otolaryngol – volume: 10 start-page: R63 year: 2006 article-title: Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study publication-title: Crit Care – volume: 34 start-page: 481 year: 2008 end-page: 487 article-title: C-reactive protein concentration as a predictor of in-hospital mortality after ICU discharge: a prospective cohort study publication-title: Intensive Care Med |
| SSID | ssj0067075 |
| Score | 2.2556746 |
| Snippet | Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic inflammation. The... Abstract Introduction: Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with... Introduction: Sudden hearing loss is a significant otologic emergency. Previous studies have revealed a coexistence of sudden hearing loss with chronic... |
| SourceID | doaj scielo pubmedcentral proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 180 |
| SubjectTerms | Adult Albumin Albumina Biomarkers - blood C-reactive protein C-Reactive Protein - analysis Case-Control Studies Chronic inflammation Female Hearing Loss, Sensorineural - blood Hearing Loss, Sensorineural - drug therapy Hearing Loss, Sudden - blood Hearing Loss, Sudden - drug therapy Humans Inflamação crônica Lymphocyte Count Male Methylprednisolone - therapeutic use Middle Aged Neutrophils Original OTORHINOLARYNGOLOGY Perda auditiva súbita Predictive Value of Tests Prognosis Proteína C-reativa Retrospective Studies Serum Albumin - analysis Sudden hearing loss Treatment Outcome |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Na9wwEBUllNJLaZN-uB9BgUIvdWvLsjQ6lTY0pIX00gZyE7Il0Q2LN2R3_39nJHuJCSSXXgzWSlqkGb15RqMnxt57p7yIri61EaqUBnwJUZvS94h9IHsBkQ44n_1Sp-fy50V7ceOqL8oJy_LAeeI-axmh7Y1xXtcydsZ0ntwMwVdXTtWe0BfD2PQxlTFY6SyxW0MFJSgjJ72hlNnVXa6uadehhk8psUvPYlKS7p-FptvU83YG5UMKWMubsenkKXsykkr-NQ_mGXsQhn326GzcNj9g3Y81R6LHj0ukiAngeNJnwI_ilJ68GHhyBO6onFLvsCPuBo-v1ElqkW_m4Vh3vSW04nQXNgY-vsQxfXnOzk--_zk-LcfLFcpe1WqD2NvJrgERhQyy8g68ANVL51rvogxNEE0PnvS-kKOZUIc-eiHBQBs6D65qXrC9YTWEV4xrpdEe0VUS64tWmL7RLkSQUHmyV8HENL22H5XH6QKMpZ1SzC5tsoklm1Ah2qRgH3eNrrLwxt3Vv5HddlVJNTsVoC_Z0Zfsfb5UMDlZ3U4HUxFKsaPF3f-tds1G3pL5yP0NjybXsriqaavGDWG1XVskYi0YnPy2YC-zq-2GhghNmkV1wfTMCWdjn_8yLP4m5XAjkbE1ULAP2V3tCFhr-5uWiqWlIio6vUUPLHr9P6b1DXtMnebMvbdsb3O9De-Qym26w7Rq_wFrtkMk priority: 102 providerName: Directory of Open Access Journals |
| Title | Is the C-reactive protein/albumin ratio a prognostic and predictive factor in sudden hearing loss? |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1808869418302611 https://dx.doi.org/10.1016/j.bjorl.2018.10.007 https://www.ncbi.nlm.nih.gov/pubmed/30522831 https://www.proquest.com/docview/2155894545 https://pubmed.ncbi.nlm.nih.gov/PMC9422438 http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1808-86942020000200180&lng=en&tlng=en https://doaj.org/article/74f85c99ad714fb99bd425734170a61d |
| Volume | 86 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: DOA dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVESC databaseName: ScienceDirect Free and Delayed Access Journal customDbUrl: eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: IXB dateStart: 20050201 isFulltext: true titleUrlDefault: https://www.sciencedirect.com providerName: Elsevier – providerCode: PRVBFR databaseName: Free Medical Journals - Free Access to All customDbUrl: eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: DIK dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: GX1 dateStart: 20090101 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVLSH databaseName: Elsevier Journals customDbUrl: mediaType: online eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: AKRWK dateStart: 20050101 isFulltext: true providerName: Library Specific Holdings – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1808-8686 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0067075 issn: 1808-8694 databaseCode: RPM dateStart: 20050101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Za9wwEBYhlNKX0qaXewQVCn2pu7Ys63gqzZKjhfSlDeybkHW0Dos37PH_OyPbS00ghbwYVjuSdYy-mV3NfCLkg7fCs2jLXGomcq6Vz1WUOvcOsE9xx1TEBOfLH-Liin9f1IsDMh9zYTCscsD-HtMTWg8ls2E2ZzdtO_tZKtghmIeJFFYi5fdWXKYkvsXJiMZC9mS7KJyj9Mg8lGK8muvVGs8fSvU5hXjJiXVKJP4TI3XbCb0dS_kAO7v810qdPSGPB_eSfu1H8JQchO6IPLwcDtCfkebbhoLLR-c5OIsJ6mhiaoCfxylQue1oUglqsRyD8KAhajsPH7GRVKO_o4eC7GaHuEXxVmwwgXQJY_rynFydnf6aX-TDNQu5E6XYAgo3vKkUi4wHXnirPFPCcWtrbyMPVWCVUx6Zv8Bb06EMLnrGlVZ1aLyyRfWCHHarLrwiVAopKx5twUGe1Uy7StoQFVeF17rxGWHj9Bo3cJDjVRhLMwabXZu0JgbXBAthTTLyaV_ppqfguFv8BNdtL4r82algtf5tBgUykkdVO62tlyWPDfYNwQtMuiysKKGjfFx1M6aoAqhCQ-3d7xb7ahMt_n_F96NqGdjfeGhju7DabQy4ZLXSMPl1Rl72qrYfGmA1sheVGZETJZyMffpN1_5JHOKag-9WqYx87NXVDNC1MWlfGdwqrMA8LnxA0ev7Du0NeYQN9XF7b8nhdr0L78CR2zbH6Q8QeJ4vyuO0a_8ChRBGcA |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYhLW0vpe86falQ6KXu2rKsx6k0S8Num82lCexNyJaUbli8YR__PzOyvdQEUujFYO1I1mP0zSya-UTIJ2eFY8HmqdRMpFwrl6ogdepqwD7Fa6YCJjjPzsTkgv-cl_MDMu5zYTCsssP-FtMjWnclo242R9eLxeh3rmCHYB4mUlgJzO-9B95AhnFd0_lxD8dCtmy7KJ2ieE89FIO8qqvVGg8gcvU1xnjJgXmKLP4DK3XbC70dTHkfe7v820ydPCGPO_-Sfm-H8JQc-OYZeTDrTtCfk2q6oeDz0XEK3mLEOhqpGuD_cYxUXjQ06gS1WI5ReNAQtY2DV2wk1mgv6aEgu9khcFG8FhtsIF3CmL69IBcnP87Hk7S7ZyGtRS62AMMVrwrFAuOeZ84qx5SoubWls4H7wrOiVg6pv8Bd0z73dXCMK61KXzlls-IlOWxWjX9NqBRSFjzYjIM8K5muC2l9UFxlTuvKJYT102vqjoQc78JYmj7a7MrENTG4JlgIa5KQL_tK1y0Hx93ix7hue1Ek0I4Fq_Wl6TTISB5UWWttncx5qLBviF5g02VmRQ4d5f2qmz5HFVAVGlrc_W2xrzZQ439X_NirloENjqc2tvGr3caAT1YqDZNfJuRVq2r7oQFYI31RnhA5UMLB2Ie_NIs_kURcc3DeCpWQz626mg67NiZuLINbhWWYyIUPKDr636F9IA8n57NTczo9-_WGPMJG2yC-t-Rwu975d-DVbav3cdfeAI33R6s |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Is+the+C-reactive+protein%2Falbumin+ratio+a+prognostic+and+predictive+factor+in+sudden+hearing+loss%3F&rft.jtitle=Brazilian+journal+of+otorhinolaryngology&rft.au=%C3%96%C3%A7al%2C+Ramazan&rft.au=Ak%C4%B1n+%C3%96%C3%A7al%2C+Fatma+Ceyda&rft.au=G%C3%BCll%C3%BCev%2C+Mustafa&rft.au=Alata%C5%9F%2C+Necat&rft.date=2020-03-01&rft.issn=1808-8694&rft.volume=86&rft.issue=2&rft.spage=180&rft.epage=184&rft_id=info:doi/10.1016%2Fj.bjorl.2018.10.007&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_bjorl_2018_10_007 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1808-8694&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1808-8694&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1808-8694&client=summon |